Hypertension in diabetes patients overtreated?

Australian and international investigators in the ADVANCE trial found in a post hoc analysis that not all patients gain equivalent benefit from BP-lowering treatment and that an algorithm based on routine clinical data could identify patients with T2DM who would benefit most from the drugs.